1) A 40-year old female patient is being followed up for diabetes mellitus. She is currently on Metformin 1 gram twice a day and has been tolerating it well for about six months. Her hemoglobin A1c a week ago was 8.9%. T
...
1) A 40-year old female patient is being followed up for diabetes mellitus. She is currently on Metformin 1 gram twice a day and has been tolerating it well for about six months. Her hemoglobin A1c a week ago was 8.9%. The plan is to initiate liraglutide therapy in addition to the metformin. Which of the following statements is true with regards to liraglutide.
▪ Liraglutide may be stored in the refrigerator or freezer prior to first use.
▪ The brand name is Bydureon
▪ Nausea and/or vomiting are common side effects of therapy
▪ It should be administered intramuscularly into the upper arm.
2) The patient who takes insulin has just been prescribed a beta blocker drug. You recognize that the interaction of the beta blocker and the insulin may have which result?
▪ Decreased activity of the beta blocker drug
▪ Enhanced activity of the beta blocker drug
▪ Masked signs of hypoglycemia
▪ Masked signs of hyperglycemia
3) The drug of choice for type 2 diabetics is metformin. Metformin:
▪ Increases intestinal uptake of glucose
▪ Decreases glycogenolysis by the liver
▪ Increases the release of insulin from beta cells
▪ Prevents weight gain associated with hyperglycemia
4) Which classification of oral hypoglycemic drugs decreases hepatic glucose production and increases insulin sensitivity and peripheral glucose uptake?
▪ Sulfonylureas (glyburide)
▪ Meglitinides (glinides)
▪ Biguanide (metformin)
CONTINUED..................
[Show More]